Business Context and Reporting Period
This Form 8-K Current Report was filed by Mustang Bio, Inc. on December 4, 2020. The report details a corporate governance action regarding the company's capital structure, specifically an amendment to its Amended and Restated Certificate of Incorporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate amendment and does not contain financial performance data.
Material Changes
- Authorized Share Increase: The company increased its authorized number of common stock shares from 85,000,000 to 125,000,000.
- Approval Process: The amendment was approved by the Board of Directors on November 11, 2020, and subsequently ratified by stockholders via written consent in lieu of a meeting.
- Effective Date: The amendment became effective upon filing the Certificate of Amendment with the Delaware Secretary of State on December 4, 2020.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risks related to operations. The primary purpose of the filing is to disclose the legal effect of the capitalization amendment. The text references an Information Statement filed on November 13, 2020, for further details on the amendment.
Investor Verification Checklist
- Verify the new total authorized share count of 125,000,000 in the company's latest capitalization table.
- Review the "Certificate of Amendment" (Exhibit 3.1) to confirm the specific language of the amendment.
- Check the Information Statement filed on November 13, 2020, for the rationale behind the share increase.
- Confirm that the written consent from stockholders covered a majority of issued and outstanding shares.